Valuation AstraZeneca PLC Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate 12:32:02 21/08/2026 pm IST			5-day change	1st Jan Change
139.78 ^EUR	-0.20%		+5.35%	-10.39%

10:23am	Nordic stocks in North America, Ericsson fell 0.9 percent	FW
20/08	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,82,034	2,09,442	2,09,268	2,03,171	2,87,813	2,55,775	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-11.13%	-	-
Enterprise Value (EV) ¹	2,06,417	2,32,365	2,31,778	2,27,741	3,11,187	2,75,101	2,67,427	2,58,922
Change	-	12.57%	-0.25%	-1.74%	36.64%	-11.6%	-2.79%	-3.18%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	21.1x	18.4x	16x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	4.75x	4.21x	3.58x
PEG	-	0x	0.4x	1.6x	0.6x	1.1x	1.2x	1.1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	4.04x	3.83x	3.59x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.35x	4x	3.63x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	12.4x	11x	9.68x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	13.1x	11.5x	10.1x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	29.2x	20.6x	17.9x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.42%	4.85%	5.59%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.325	3.528	3.662
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	2.02%	2.14%	2.22%
EPS ²	0.08	2.11	3.81	4.5	6.54	7.807	8.959	10.31
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	42.6%	39.4%	35.5%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,248	66,838	71,269
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,271	24,391	26,737
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,047	23,260	25,555
Net income ¹	112	3,288	5,961	7,035	10,225	12,070	13,716	15,668
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	19,326	11,652	3,147
Reference price ²	117.51	135.16	135.02	131.05	185.60	164.91	164.91	164.91
Nbr of stocks (in thousands)	15,49,159	15,49,528	15,49,926	15,50,317	15,50,726	15,51,024	-	-
Announcement Date	10/02/22	09/02/23	08/02/24	06/02/25	10/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.55x	12.84x	26.06x	0.55%	1,10900Cr
JOHNSON & JOHNSON	29.74x	-	-	2.01%	64TCr
ABBVIE INC.	33.42x	7.74x	16.11x	2.62%	46TCr
ROCHE HOLDING AG	20.72x	4.91x	12.16x	2.69%	37TCr
NOVARTIS AG	22.47x	5.78x	14.33x	2.76%	30TCr
ASTRAZENECA PLC	21.12x	4.35x	12.35x	2.02%	26TCr
AMGEN INC.	27.43x	7.09x	12.59x	2.33%	23TCr
NOVO NORDISK A/S	13.47x	4.79x	10.05x	3.81%	20TCr
GILEAD SCIENCES, INC.	-43.83x	6.34x	24.76x	2.3%	18TCr
Average	17.79x	6.73x	16.05x	2.34%	41.79TCr
Weighted average by Cap.	25.34x	8.43x	18.53x	1.91%